Literature DB >> 18184827

Early diagnosis of leptospirosis by immunoglobulin M immunoblot testing.

Galayanee Doungchawee1, Uraiwan Kositanont, Anuchai Niwetpathomwat, Tasanee Inwisai, Plyyonk Sagarasaeranee, David A Haake.   

Abstract

There is an urgent need for the development of serodiagnostic approaches with improved sensitivity for patients with acute leptospirosis. Immunoblots were performed on 188 sera collected from 74 patients with laboratory-confirmed early leptospiral infection to detect immunoglobulin M (IgM) antibodies to antigens pooled from 10 leptospiral strains prevalent in Thailand. Sera from patients with other febrile diseases served as controls. IgM reactivity to seven distinct antigens, with apparent molecular masses of 14 to 18, 19 to 23, 24 to 30, 32, 35/36, 37, and 41/42 kDa, was observed. The low-molecular-mass 14- to 18-kDa band was the most frequently detected antigen, being recognized in sera from 82.4% of patients during the first 3 days after the onset of symptoms. We evaluated the accuracy of the IgM immunoblot (IgM-IB) test by using reactivity to the 14- to 18-kDa band and/or at least two bands among the 19- to 23-, 24- to 30-, 32-, 35/36-, 37-, and 41/42-kDa antigens as the diagnostic criterion. The sensitivities of the IgM-IB test and the microscopic agglutination test (MAT) were 88.2% and 2.0%, respectively, with sera from patients 1 to 3 days after the onset of symptoms. In contrast, the IgM-IB test was positive with only 2/48 (4.2%) sera from patients with other febrile illnesses. The high sensitivity and specificity of the IgM-IB test for acute leptospirosis would provide greatly improved diagnostic accuracy for identification of patients who would benefit from early antibiotic intervention. In addition, the antigens identified by the IgM-IB test may serve as components of a rapid, accurate, point-of-care diagnostic test for early leptospirosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18184827      PMCID: PMC2268276          DOI: 10.1128/CVI.00152-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  47 in total

Review 1.  Leptospirosis.

Authors:  P N Levett
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Detection of dengue infection in patients investigated for leptospirosis in Barbados.

Authors:  P N Levett; S L Branch; C N Edwards
Journal:  Am J Trop Med Hyg       Date:  2000-01       Impact factor: 2.345

3.  Characterization of the leptospiral outer membrane and description of three novel leptospiral membrane proteins.

Authors:  David A Haake; James Matsunaga
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

4.  Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans.

Authors:  H Guerreiro; J Croda; B Flannery; M Mazel; J Matsunaga; M Galvão Reis; P N Levett; A I Ko; D A Haake
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

5.  Assessment of the efficacy of an IgM-elisa and microscopic agglutination test (MAT) in the diagnosis of acute leptospirosis.

Authors:  P Cumberland; C O Everard; P N Levett
Journal:  Am J Trop Med Hyg       Date:  1999-11       Impact factor: 2.345

Review 6.  Antibiotics for treating leptospirosis.

Authors:  F Guidugli; A A Castro; A N Atallah
Journal:  Cochrane Database Syst Rev       Date:  2000

7.  Evaluation of recombinant Leptospira antigen-based enzyme-linked immunosorbent assays for the serodiagnosis of leptospirosis.

Authors:  B Flannery; D Costa; F P Carvalho; H Guerreiro; J Matsunaga; E D Da Silva; A G Ferreira; L W Riley; M G Reis; D A Haake; A I Ko
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

8.  Molecular cloning and sequence analysis of the gene encoding LipL41, a surface-exposed lipoprotein of pathogenic Leptospira species.

Authors:  E S Shang; T A Summers; D A Haake
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

Review 9.  Leptospirosis.

Authors:  J M Vinetz
Journal:  Curr Opin Infect Dis       Date:  2001-10       Impact factor: 4.915

Review 10.  Leptospiral nephropathy.

Authors:  Visith Sitprija; Kitti Losuwanrak; Talerngsak Kanjanabuch
Journal:  Semin Nephrol       Date:  2003-01       Impact factor: 5.299

View more
  9 in total

1.  Association between Opisthorchis viverrini and Leptospira spp. infection in endemic Northeast Thailand.

Authors:  Chinh Dang Van; Galayanee Doungchawee; Sutas Suttiprapa; Yuji Arimatsu; Sasithorn Kaewkes; Banchob Sripa
Journal:  Parasitol Int       Date:  2016-10-13       Impact factor: 2.230

2.  Evaluation of different serological assays for early diagnosis of leptospirosis in Martinique (French West Indies).

Authors:  Christophe Courdurie; Yohann Le Govic; Pascale Bourhy; Dorothee Alexer; Karine Pailla; Rafaelle Theodose; Raymond Cesaire; Jacques Rosine; Patrick Hochedez; Claude Olive
Journal:  PLoS Negl Trop Dis       Date:  2017-06-23

3.  Evaluation of leptospiral recombinant antigens MPL17 and MPL21 for serological diagnosis of leptospirosis by enzyme-linked immunosorbent assays.

Authors:  Tatiane R Oliveira; Mariana T Longhi; Zenaide M de Morais; Eliete C Romero; Roberta M Blanco; Karin Kirchgatter; Silvio A Vasconcellos; Ana L T O Nascimento
Journal:  Clin Vaccine Immunol       Date:  2008-09-17

4.  Detection of Leptospira-specific antibodies using a recombinant antigen-based enzyme-linked immunosorbent assay.

Authors:  Hua-Wei Chen; Zhiwen Zhang; Eric S Halsey; Carolina Guevara; Enrique Canal; Eric Hall; Ryan Maves; Drake H Tilley; Tadeusz J Kochel; Wei-Mei Ching
Journal:  Am J Trop Med Hyg       Date:  2013-10-28       Impact factor: 2.345

5.  Sensitivity and Specificity of a New Vertical Flow Rapid Diagnostic Test for the Serodiagnosis of Human Leptospirosis.

Authors:  Cyrille Goarant; Pascale Bourhy; Eric D'Ortenzio; Sylvie Dartevelle; Carine Mauron; Marie-Estelle Soupé-Gilbert; Lilian Bruyère-Ostells; Ann-Claire Gourinat; Mathieu Picardeau; Faridabano Nato; Suzanne Chanteau
Journal:  PLoS Negl Trop Dis       Date:  2013-06-27

6.  2010 ACVIM small animal consensus statement on leptospirosis: diagnosis, epidemiology, treatment, and prevention.

Authors:  J E Sykes; K Hartmann; K F Lunn; G E Moore; R A Stoddard; R E Goldstein
Journal:  J Vet Intern Med       Date:  2010-12-13       Impact factor: 3.333

7.  Role of 72 kDa protein of Leptospira interrogans as a diagnostic marker in acute leptospirosis.

Authors:  M Riazi; F Z Zainul; A R Bahaman; F Amran; A Khalilpour
Journal:  Indian J Med Res       Date:  2014-02       Impact factor: 2.375

8.  Development and evaluation of an immunochromatographic assay to detect serum anti-leptospiral lipopolysaccharide IgM in acute leptospirosis.

Authors:  Galayanee Doungchawee; Direk Sutdan; Kannika Niwatayakul; Tasanee Inwisai; Athisri Sitthipunya; Naphatsawan Boonsathorn; Titipatima Sakulterdkiat; Worachart Sirawaraporn; Visith Thongboonkerd
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

9.  Evaluation of a genus-specific rGroEL1-524 IgM-ELISA and commercial ELISA kits during the course of leptospirosis in Thailand.

Authors:  Santi Maneewatchararangsri; Galayanee Doungchawee; Thareerat Kalambaheti; Viravarn Luvira; Ngamphol Soonthornworasiri; Pisut Vattanatham; Urai Chaisri; Poom Adisakwattana
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.